<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Korean J Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">KJLM</journal-id>
      <journal-title-group>
        <journal-title>The Korean Journal of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1598-6535</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22016687</article-id>
      <article-id pub-id-type="pmc">3190012</article-id>
      <article-id pub-id-type="doi">10.3343/kjlm.2011.31.4.298</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
          <subj-group>
            <subject>Clinical Microbiology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Isolation of a <italic>Klebsiella pneumoniae</italic> Isolate of Sequence Type 258 Producing KPC-2 Carbapenemase in Korea</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Roh</surname>
            <given-names>Kyoung Ho</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Chang Kyu</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sohn</surname>
            <given-names>Jang Wook</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Song</surname>
            <given-names>Wonkeun</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yong</surname>
            <given-names>Dongeun</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Kyungwon</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Laboratory Medicine, Korea University College of Medicine, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.</aff>
      <aff id="A3"><label>3</label>Department of Laboratory Medicine, Hallym University College of Medicine, Seoul, Korea.</aff>
      <aff id="A4"><label>4</label>Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Wonkeun Song, M.D. Department of Laboratory Medicine, Kangnam Sacred Heart Hospital, 948-1 Daerim 1-dong, Youngdeungpo-gu, Seoul 150-950, Korea. Tel: +82-2-829-5259, Fax: +82-2-847-2403, <email>swonkeun@hallym.or.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>10</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>03</day>
        <month>10</month>
        <year>2011</year>
      </pub-date>
      <volume>31</volume>
      <issue>4</issue>
      <fpage>298</fpage>
      <lpage>301</lpage>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>4</month>
          <year>2011</year>
        </date>
        <date date-type="rev-recd">
          <day>13</day>
          <month>6</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>7</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2011 The Korean Society for Laboratory Medicine</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Carbapenem-resistant <italic>Klebsiella pneumoniae</italic> isolates producing <italic>K. pneumoniae</italic> carbapenemases (KPC) were first reported in the USA in 2001, and since then, this infection has been reported in Europe, Israel, South America, and China. In Korea, the first KPC-2-producing <italic>K. pneumoniae</italic> sequence type (ST) 11 strain was detected in 2010. We report the case of a patient with a urinary tract infection caused by KPC-2-producing <italic>K. pneumoniae</italic>. This is the second report of a KPC-2-producing <italic>K. pneumoniae</italic> infection in Korea, but the multilocus sequence type was ST258. The KPC-2-producing isolate was resistant to all tested &#x3B2;-lactams (including imipenem and meropenem), amikacin, tobramycin, ciprofloxacin, levofloxacin, and trimethoprim-sulfamethoxazole, but was susceptible to gentamicin, colistin, polymyxin B, and tigecycline. The KPC-2-producing isolate was negative to phenotypic extended-spectrum &#x3B2;-lactamase (ESBL) and AmpC detection tests and positive to modified Hodge test and carbapenemase inhibition test with aminophenylboronic acid.</p>
      </abstract>
      <kwd-group>
        <kwd>KPC-2</kwd>
        <kwd>
          <italic>Klebsiella pneumoniae</italic>
        </kwd>
        <kwd>ST258</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>The resistance of <italic>Klebsiella pneumoniae</italic> to carbapenems is mainly associated with acquired carbapenemases [<xref ref-type="bibr" rid="B1">1</xref>]. These carbapenemases can be Ambler class A (KPC, GES), class B (VIM, IMP), and class D (OXA-48) enzymes [<xref ref-type="bibr" rid="B2">2</xref>]. The most common class A carbapenemases in <italic>K. pneumoniae</italic> are the <italic>K. pneumoniae</italic> carbapenemases (KPCs) [<xref ref-type="bibr" rid="B3">3</xref>]. KPC-producing <italic>K. pneumoniae</italic> strains were first reported in 2001 in the USA [<xref ref-type="bibr" rid="B4">4</xref>] and dissemination has been reported in Europe, Israel, South America, and China [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B9">9</xref>]. The first KPC-2-producing <italic>K. pneumoniae</italic> strain in Korea was isolated from bronchial aspirates from a patient admitted to the intensive care unit (ICU) in 2010 [<xref ref-type="bibr" rid="B10">10</xref>]. KPC-producing <italic>K. pneumoniae</italic> also produce VIM or CTX-M, making it difficult to select appropriate antibiotics [<xref ref-type="bibr" rid="B11">11</xref>]. In addition, the mortality rate is significantly higher for patients with KPC-producing isolates than those with imipenem susceptible isolates [<xref ref-type="bibr" rid="B12">12</xref>]. In this report, we describe a case of infection with a KPC-2-producing <italic>K. pneumoniae</italic> isolate, sequence type (ST) 258 in Korea and various phenotypic methods for screening and confirmation.</p>
    </sec>
    <sec sec-type="cases">
      <title>CASE REPORT</title>
      <p>A 70-year-old woman was admitted to the Plastic Surgery (PS) department on October 5, 2010, with a 24-h history of fever and dizziness. She had a known history of unstable angina and diabetes mellitus (2001). In November 2009, she was admitted to the PS department for a skin flap operation (February, 2010) to treat a third-degree burn to the sacral area. Two months ago, a sore, approximately 10&#xD7;10 cm in size, developed at the sacral area and progressed to osteomyelitis in the sacral bone. She had no recent travel history abroad. At admission, she was pale and febrile with a temperature of 38.2&#x2103;. An intermittent fever of 37.3-38.1&#x2103; lasted until hospital day (HD) 5. Her blood pressure was 110/80 mmHg, her pulse was 78/min, and her respiratory rate was 20/min. A laboratory investigation at the time of admission revealed a peripheral white blood cell (WBC) count of 8,730/&#xB5;L (73.5% neutrophils), a hemoglobin level of 8.6 g/dL, and a platelet count of 261,000/&#xB5;L. Routine blood chemistry results were AST/ALT of 7/11 U/L, alkaline phosphatase of 77 U/L, blood urea nitrogen/creatinine of 23.4/1.42 mg/dL, and total protein/albumin of 5.6/2.9 g/dL. Erythrocyte sedimentation rate and C-reactive protein were both increased to 53 mm/hr and 220.03 mg/L, respectively. The urine was yellow and turbid and routine urinalysis revealed a positive WBC (3+), and positive protein (1+). Microscopic examination of urine revealed &gt;60 WBCs and yeast organisms in a high power field. A chest radiograph showed right pleural thickening and a little collapse of the right lower lung. An abdomen and pelvic computed tomography showed signs of cystitis and fluid collection in both the abdomen and pleural cavity.</p>
      <p>Two sets of blood culture bottles and a urine sample were taken for microbiologic study. Aerobic and anaerobic blood cultures were all negative after 5 days of incubation. In the urine culture, <italic>Candida albicans</italic> (8&#xD7;10<sup>4</sup> CFU/mL) grew on a blood agar plate. On HD 32, the patient had a fever of 38.1&#x2103;. Two sets of blood culture bottles and a urine sample were collected again for culture study. The blood culture results were negative. Multidrug-resistant <italic>K. pneumoniae</italic> (KPN 1010, &gt;10<sup>5</sup> CFU/mL) was isolated from the urine. Vitek2 GN and AST-N044 (bioM&#xE9;rieux, Marcy l'&#xC9;toile, France) were used for species identification and antimicrobial susceptibility test, respectively. With the exception of gentamicin, all susceptibility results showed high-level minimum inhibitory concentration (MIC) values. MICs were also assessed by E-test (bioM&#xE9;rieux). Most antibiotics were resistant and consistent with the MIC of Vitek2. However, MICs of tigecycline and colistin were 1 and 0.25 &#xB5;g/mL, respectively (<xref ref-type="table" rid="T1">Table 1</xref>). The modified Hodge test [<xref ref-type="bibr" rid="B13">13</xref>] demonstrated strong positivity (<xref ref-type="fig" rid="F1">Fig. 1A</xref>) but AmpC and ESBL phenotypic tests [<xref ref-type="bibr" rid="B14">14</xref>] were negative. Carbapenemase inhibition tests were performed for discrimination of carbapenemases. Briefly, meropenem disks (Becton-Dickinson, Cockeysville, MD, USA) were supplemented with 10 &#xB5;L of 4 different &#x3B2;-lactamase inhibitors: 60 mg/mL aminophenylboronic acid (APB; Sigma St. Louis, MO, USA), 75 mg/mL cloxacillin (Sigma), 100 mg/mL dipicolinic acid (DPA; Sigma), and 0.2 M ethylenediaminetetraacetic acid (EDTA; Sigma). A 0.5 McFarland inoculum was prepared and spread on Mueller-Hinton agar plates (Becton-Dickinson). Five disks were placed on each plate: meropenem, meropenem+APB, meropenem+cloxacillin, meropenem+DPA, meropenem+EDTA. A positive response was achieved when there was a greater than 5 mm increase of the inhibition zone diameter around disks containing &#x3B2;-lactamase inhibitors, as compared with the meropenem disk alone [<xref ref-type="bibr" rid="B15">15</xref>]. The positive result was seen only with APB (<xref ref-type="fig" rid="F1">Fig. 1B</xref>).</p>
      <p>PCR and DNA sequencing were performed with primers specific for the <italic>bla</italic><sub>VIM</sub>, <italic>bla</italic><sub>IMP</sub>, <italic>bla</italic><sub>SIM</sub>, <italic>bla</italic><sub>NDM</sub>, and <italic>bla</italic><sub>KPC</sub> genes [<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. We found only the <italic>bla</italic><sub>KPC-2</sub> gene. Multilocus sequence typing (MLST) with 7 housekeeping genes (<italic>rpoB</italic>, <italic>gapA</italic>, <italic>mdh</italic>, <italic>pgi</italic>, <italic>phoE</italic>, <italic>infB</italic>, and <italic>tonB</italic>) was performed [<xref ref-type="bibr" rid="B19">19</xref>]. The MLST showed that the isolate belonged to the epidemic clone ST258. Initially, the patient was treated with ertapenem (1 g once a day). After multidrug-resistant (MDR) <italic>K. pneumoniae</italic> was isolated from urine and the sacral sore wound, tigecycline (50 mg twice a day) was administrated for 14 days. However, neither pyuria nor the wound subsided, and MDR <italic>K. pneumoniae</italic> was repeatedly isolated. Lastly, the patient was treated with colistin (150 mg once a day), but clinical improvement was not observed and kidney function was declining. She was managed in ICU, but expired on the 90th HD due to septic shock and multiorgan failure.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The most common mechanism of carbapenem-resistant <italic>K. pneumoniae</italic> in Korea is ESBL and/or AmpC &#x3B2;-lactamase plus porin loss [<xref ref-type="bibr" rid="B20">20</xref>]. Only a single case of KPC-2-producing strain has been described in Korea and the MLST type was ST11 [<xref ref-type="bibr" rid="B10">10</xref>]. This isolate showed an MDR pattern to various antibiotics, including colistin. The previous patient was treated with colistin, but the prognosis was also poor. This is the second report of a KPC-2-producing <italic>K. pneumoniae</italic> in Korea. The isolate was not associated with travel and the MLST type was ST258. ST258 accounts for 70% of KPC-producing <italic>K. pneumoniae</italic> in the USA [<xref ref-type="bibr" rid="B21">21</xref>]. Isolates of ST258 have also been identified in Europe and Israel, indicating an international spread of ST258 among KPC-producing <italic>K. pneumoniae</italic> [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>].</p>
      <p>Most KPC-producing <italic>K. pneumoniae</italic> have been associated with other &#x3B2;-lactamase genes, such as the widespread ESBL gene <italic>bla</italic><sub>CTX-M</sub> [<xref ref-type="bibr" rid="B22">22</xref>]. The previous KPC-2-producing <italic>K. pneumoniae</italic> isolate in Korea also contained <italic>bla</italic><sub>CTX-M-15</sub> [<xref ref-type="bibr" rid="B10">10</xref>]. However, the KPN 1010 isolate contained neither ESBL nor AmpC gene in this study.</p>
      <p>The KPN 1010 isolate was susceptible to gentamicin, colistin, polymyxin B, and tigecycline, but the previous Korean isolate was nonsusceptible to gentamicin, colistin, polymyxin B, and tigecycline [<xref ref-type="bibr" rid="B10">10</xref>].</p>
      <p>A modified Hodge test accurately detects KPC, but is not able to discriminate from other carbapenemases [<xref ref-type="bibr" rid="B23">23</xref>]. A carbapenemase inhibition test, comprising a meropenem disk, and meropenem disks supplemented with APB (for detection of class A carbapenemases), cloxacillin (for detection of AmpC &#x3B2;-lactamases plus porin loss), DPA or EDTA (for detection of class B metallo-carbapenemases) accurately distinguishes between several different mechanisms mediating reduced susceptibility to carbapenems in <italic>Enterobacteriaceae</italic> [<xref ref-type="bibr" rid="B15">15</xref>]. The isolate was positive to APB and negative to cloxacillin, DPA, and EDTA, suggesting a class A carbapenemase producing isolate.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>No potential conflict of interest relevant to this article was reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nordmann</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Poirel</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Emerging carbapenemases in Gram-negative aerobes</article-title>
          <source>Clin Microbiol Infect</source>
          <year>2002</year>
          <volume>8</volume>
          <fpage>321</fpage>
          <lpage>331</lpage>
          <pub-id pub-id-type="pmid">12084099</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Queenan</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Bush</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Carbapenemases: the versatile &#x3B2;-lactamases</article-title>
          <source>Clin Microbiol Rev</source>
          <year>2007</year>
          <volume>20</volume>
          <fpage>440</fpage>
          <lpage>458</lpage>
          <pub-id pub-id-type="pmid">17630334</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nordmann</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cuzon</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Naas</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The real threat of <italic>Klebsiella pneumoniae</italic> carbapenemase-producing bacteria</article-title>
          <source>Lancet Infect Dis</source>
          <year>2009</year>
          <volume>9</volume>
          <fpage>228</fpage>
          <lpage>236</lpage>
          <pub-id pub-id-type="pmid">19324295</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yigit</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Queenan</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Domenech-Sanchez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Biddle</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Steward</surname>
              <given-names>CD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Novel carbapenem-hydrolyzing &#x3B2;-lactamase, KPC-1, from a carbapenem-resistant strain of <italic>Klebsiella pneumoniae</italic></article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2001</year>
          <volume>45</volume>
          <fpage>1151</fpage>
          <lpage>1161</lpage>
          <pub-id pub-id-type="pmid">11257029</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giakkoupi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pappa</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Polemis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vatopoulos</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Miriagou</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Zioga</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Emerging <italic>Klebsiella pneumoniae</italic> isolates coproducing KPC-2 and VIM-1 carbapenemases</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2009</year>
          <volume>53</volume>
          <fpage>4048</fpage>
          <lpage>4050</lpage>
          <pub-id pub-id-type="pmid">19581459</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Navon-Venezia</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Leavitt</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schwaber</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Rasheed</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Srinivasan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>JB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>First report on a hyperepidemic clone of KPC-3-producing <italic>Klebsiella pneumoniae</italic> in Israel genetically related to a strain causing outbreaks in the United States</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2009</year>
          <volume>53</volume>
          <fpage>818</fpage>
          <lpage>820</lpage>
          <pub-id pub-id-type="pmid">19029323</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Samuelsen</surname>
              <given-names>&#xD8;</given-names>
            </name>
            <name>
              <surname>Naseer</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Tofteland</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Skutlaberg</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Onken</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hjetland</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Emergence of clonally related <italic>Klebsiella pneumoniae</italic> isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2009</year>
          <volume>63</volume>
          <fpage>654</fpage>
          <lpage>658</lpage>
          <pub-id pub-id-type="pmid">19218573</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Villegas</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Lolans</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Correa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Suarez</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Vallejo</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of <italic>Klebsiella pneumoniae</italic> from South America</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2006</year>
          <volume>50</volume>
          <fpage>2880</fpage>
          <lpage>2882</lpage>
          <pub-id pub-id-type="pmid">16870793</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wei</surname>
              <given-names>ZQ</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>XX</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>YG</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>LJ</given-names>
            </name>
          </person-group>
          <article-title>Plasmid-mediated KPC-2 in a <italic>Klebsiella pneumoniae</italic> isolate from China</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2007</year>
          <volume>51</volume>
          <fpage>763</fpage>
          <lpage>765</lpage>
          <pub-id pub-id-type="pmid">17145797</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rhee</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>YK</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>MY</given-names>
            </name>
            <name>
              <surname>Peck</surname>
              <given-names>KR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>KPC-producing extreme drug-resistant <italic>Klebsiella pneumoniae</italic> isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2010</year>
          <volume>54</volume>
          <fpage>2278</fpage>
          <lpage>2279</lpage>
          <pub-id pub-id-type="pmid">20211897</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pournaras</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Poulou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Voulgari</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Vrioni</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kristo</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Tsakris</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Detection of the new metallo-&#x3B2;-lactamase VIM-19 along with KPC-2, CMY-2 and CTX-M-15 in <italic>Klebsiella pneumoniae</italic></article-title>
          <source>J Antimicrob Chemother</source>
          <year>2010</year>
          <volume>65</volume>
          <fpage>1604</fpage>
          <lpage>1607</lpage>
          <pub-id pub-id-type="pmid">20522444</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marchaim</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Navon-Venezia</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schwaber</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Carmeli</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Isolation of imipenem-resistant <italic>Enterobacter</italic> species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2008</year>
          <volume>52</volume>
          <fpage>1413</fpage>
          <lpage>1418</lpage>
          <pub-id pub-id-type="pmid">18227191</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Yong</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Yum</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Seo</surname>
              <given-names>YH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Improved performance of the modified Hodge test with MacConkey agar for screening carbapenemase-producing Gram-negative bacilli</article-title>
          <source>J Microbiol Methods</source>
          <year>2010</year>
          <volume>83</volume>
          <fpage>149</fpage>
          <lpage>152</lpage>
          <pub-id pub-id-type="pmid">20801167</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Song</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Roh</surname>
              <given-names>KH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC &#x3B2;-lactamases and extended-spectrum &#x3B2;-lactamases in clinical isolates of <italic>Klebsiella</italic> spp., <italic>Salmonella</italic> spp., and <italic>Proteus mirabilis</italic></article-title>
          <source>Diagn Microbiol Infect Dis</source>
          <year>2007</year>
          <volume>57</volume>
          <fpage>315</fpage>
          <lpage>318</lpage>
          <pub-id pub-id-type="pmid">17174510</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giske</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Gezelius</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Samuelsen</surname>
              <given-names>&#xD8;</given-names>
            </name>
            <name>
              <surname>Warner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sundsfjord</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Woodford</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>A sensitive and specific phenotypic assay for detection of metallo-&#x3B2;-lactamases and KPC in <italic>Klebsiella pneumoniae</italic> with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin</article-title>
          <source>Clin Microbiol Infect</source>
          <year>2011</year>
          <volume>17</volume>
          <fpage>552</fpage>
          <lpage>556</lpage>
          <pub-id pub-id-type="pmid">20597925</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patzer</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Weeks</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dzierzanowska</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Toleman</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2009</year>
          <volume>63</volume>
          <fpage>269</fpage>
          <lpage>273</lpage>
          <pub-id pub-id-type="pmid">19095681</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith Moland</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hanson</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>Herrera</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Lockhart</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Hossain</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Plasmid-mediated, carbapenem-hydrolysing &#x3B2;-lactamase, KPC-2, in <italic>Klebsiella pneumoniae</italic> isolates</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2003</year>
          <volume>51</volume>
          <fpage>711</fpage>
          <lpage>714</lpage>
          <pub-id pub-id-type="pmid">12615876</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zarfel</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hoenigl</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Leitner</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Salzer</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Feierl</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Masoud</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Emergence of New Delhi metallo-&#x3B2;-lactamase, Austria</article-title>
          <source>Emerg Infect Dis</source>
          <year>2011</year>
          <volume>17</volume>
          <fpage>129</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="pmid">21192874</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diancourt</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Passet</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Verhoef</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Grimont</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Brisse</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Multilocus sequence typing of <italic>Klebsiella pneumoniae</italic> nosocomial isolates</article-title>
          <source>J Clin Microbiol</source>
          <year>2005</year>
          <volume>43</volume>
          <fpage>4178</fpage>
          <lpage>4182</lpage>
          <pub-id pub-id-type="pmid">16081970</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>YG</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum &#x3B2;-lactamase-producing <italic>Klebsiella pneumoniae</italic> and <italic>Escherichia coli</italic></article-title>
          <source>Diagn Microbiol Infect Dis</source>
          <year>2011</year>
          <comment>in press</comment>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kitchel</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rasheed</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Srinivasan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Navon-Venezia</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Carmeli</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular epidemiology of KPC-producing <italic>Klebsiella pneumoniae</italic> isolates in the United States: clonal expansion of multilocus sequence type 258</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2009</year>
          <volume>53</volume>
          <fpage>3365</fpage>
          <lpage>3370</lpage>
          <pub-id pub-id-type="pmid">19506063</pub-id>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cai</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>GX</given-names>
            </name>
          </person-group>
          <article-title>Emergence of <italic>Serratia marcescens</italic>, <italic>Klebsiella pneumoniae</italic>, and <italic>Escherichia coli</italic> Isolates possessing the plasmid-mediated carbapenem-hydrolyzing &#x3B2;-lactamase KPC-2 in intensive care units of a Chinese hospital</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2008</year>
          <volume>52</volume>
          <fpage>2014</fpage>
          <lpage>2018</lpage>
          <pub-id pub-id-type="pmid">18332176</pub-id>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>KF</given-names>
            </name>
            <name>
              <surname>Lonsway</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Rasheed</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Biddle</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>McDougal</surname>
              <given-names>LK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of methods to identify the <italic>Klebsiella pneumoniae</italic> carbapenemase in <italic>Enterobacteriaceae</italic></article-title>
          <source>J Clin Microbiol</source>
          <year>2007</year>
          <volume>45</volume>
          <fpage>2723</fpage>
          <lpage>2725</lpage>
          <pub-id pub-id-type="pmid">17581941</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>Results obtained with a Modified Hodge test (A) and carbapenemase inhibition test (B) for carbapenem-resistant <italic>Klebsiella pneumoniae</italic> isolate (KPN 1010).</p>
        <p>Abbreviations: MEM, meropenem; APB, aminophenylboronic acid; CLX, cloxacillin; EDTA, ethylenediaminetetraacetic acid; DPA, dipicolinic acid.</p>
      </caption>
      <graphic xlink:href="kjlm-31-298-g001"/>
    </fig>
    <table-wrap id="T1" position="float">
      <label>Table 1</label>
      <caption>
        <p>MICs (&#xB5;g/mL) of the KPC-2-producing <italic>Klebsiella pneumoniae</italic> isolate</p>
      </caption>
      <graphic xlink:href="kjlm-31-298-i001"/>
      <table-wrap-foot>
        <fn>
          <p>Abbreviations: MIC, minimum inhibitory concentration; KPC, <italic>K. pneumoniae</italic> carbapenemase.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
